Medicamen Biotech Approves Major Capital Raise via Allotment of Shares and Warrants at ₹530 Each

Unknown Apr 02, 2026 900 Views

Medicamen Biotech Ltd has announced a significant capital infusion through the preferential allotment of equity shares and fully convertible warrants, both priced at ₹530 each, as approved by its Board of Directors on February 26, 2025. Key Highlights: The Board approved th...